Wyatt David, Parker Katrina L, Kemp Stephen F, Chiang Jane, Davis D Aaron
Medical College of Wisconsin, 9000 West Wisconsin Avenue, MC C520, P.O. Box 1997, Milwaukee, WI 53201-1997, USA.
Int J Pediatr Endocrinol. 2010;2010:652013. doi: 10.1155/2010/652013. Epub 2010 Jun 24.
Objective. To characterize the pediatric endocrinologists' evaluation and followup of short-statured patients. Study Design. Observational study of 21,548 short-statured children (April 1996 to December 1999). Baseline demographics, laboratory testing, height standard deviation score (SDS), target height, and height relative to target height were analyzed at initial and return visits with the specialist. Patients were scheduled for at least one return visit and no recombinant human growth hormone therapy was administered. Results. Mean patient age was 8.6 years with a mean height SDS of -2.1. Patients were predominantly male (69%), prepubertal (73%), and white (76%). Few screening tests were obtained during initial evaluation. Nearly 40% of children did not return for their second scheduled visit. The follow-up rate was unrelated to demographics or degree of short stature. Conclusions. Low return rates limit specialists' ability to monitor growth or obtain laboratory testing over time. Further studies are needed to determine which tests should be obtained at the initial clinic visit as well as the basis for the low return rate in this group of children.
目的。描述儿科内分泌专家对身材矮小患者的评估及随访情况。研究设计。对21548名身材矮小儿童进行观察性研究(1996年4月至1999年12月)。在初次就诊及复诊时分析患者的基线人口统计学资料、实验室检查、身高标准差评分(SDS)、靶身高以及相对于靶身高的身高情况。患者至少安排了一次复诊,且未接受重组人生长激素治疗。结果。患者平均年龄为8.6岁,平均身高SDS为 -2.1。患者以男性(69%)、青春期前儿童(73%)和白人(76%)为主。初次评估时进行的筛查检查较少。近40%的儿童未按计划进行第二次复诊。随访率与人口统计学资料或身材矮小程度无关。结论。低复诊率限制了专家长期监测生长情况或进行实验室检查的能力。需要进一步研究以确定在初次门诊就诊时应进行哪些检查,以及该组儿童复诊率低的原因。